StonvexLoading…
StonvexStonvexStonvexCore line items from PJT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.70B | $1.48B | $1.15B | $1.03B |
Operating Income | $342.92M | $270.57M | $177.61M | $201.47M |
Net Income | $180.12M | $134.39M | $81.80M | $90.53M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $1.84B | $1.64B | $1.43B | $1.05B |
Total Liabilities | $834.21M | $733.69M | $573.81M | $291.09M |
Cash & Equivalents | $538.86M | $483.88M | $355.54M | $173.24M |
Free Cash Flow OCF − CapEx | $480.44M | $527.65M | $437.61M | $239.30M |
Shares Outstanding | Not available | Not available | Not available | Not available |